PCM Task Force Chair: Andreas Lundqvist
The immune system plays an important role in response to oncological therapy, and profiling of the immune system can help to identify biomarkers to guide treatment decisions and prognosis. If you are interested in how we can assist in immune profiling, please contact Andreas Lundqvist (andreas.lundqvist@ki.se).
Position paper by PCM Program steering group members Eskil Degsell and Mats Brommels on the need for a change in perspective in the collaboration between patient, relatives and Health care providers.
Datum: February 5, 2024
Plats: IRCCS - Istituto Nazionale dei Tumori, Milano
Information: Cancer Core Europe’s Annual Meeting 2024
Datum: January 31, 2024
Plats: Life City, Solnavägen 3H, Solna
Information: Panel: The future of health: How can patient reported data lead to improved treatments?
